Moreover, a similar level of the antiapoptotic Bcl-2 is also detected in the HOXA-positive T-ALL subgroup, whereas mature T-ALL is often characterized by TAL1 or Lmo2 oncogene activation, displaying low levels of Bcl-2 [23]. This evidence concerns the gene BCL2 and acute lymphoblastic leukemia.